Gilde Healthcare picks up Sanquin Reagents
Sanquin Reagents is the first investment of Gilde Healthcare's €517 million Private Equity Fund IV.
Sanquin Reagents is the first investment of Gilde Healthcare's €517 million Private Equity Fund IV.
Copyright PEI Media
Not for publication, email or dissemination
